DE3856199D1 - Impfstoff gegen cholera - Google Patents

Impfstoff gegen cholera

Info

Publication number
DE3856199D1
DE3856199D1 DE3856199T DE3856199T DE3856199D1 DE 3856199 D1 DE3856199 D1 DE 3856199D1 DE 3856199 T DE3856199 T DE 3856199T DE 3856199 T DE3856199 T DE 3856199T DE 3856199 D1 DE3856199 D1 DE 3856199D1
Authority
DE
Germany
Prior art keywords
vaccine against
against cholera
cholera
protein
killed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3856199T
Other languages
English (en)
Other versions
DE3856199T2 (de
Inventor
John Mekalanos
Ronald Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of DE3856199D1 publication Critical patent/DE3856199D1/de
Application granted granted Critical
Publication of DE3856199T2 publication Critical patent/DE3856199T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/107Vibrio
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE3856199T 1987-04-29 1988-04-29 Impfstoff gegen cholera Expired - Lifetime DE3856199T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4390787A 1987-04-29 1987-04-29
PCT/US1988/001409 WO1988008431A1 (en) 1987-04-29 1988-04-29 Cholera vaccines

Publications (2)

Publication Number Publication Date
DE3856199D1 true DE3856199D1 (de) 1998-07-09
DE3856199T2 DE3856199T2 (de) 1999-02-04

Family

ID=21929523

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3856199T Expired - Lifetime DE3856199T2 (de) 1987-04-29 1988-04-29 Impfstoff gegen cholera

Country Status (8)

Country Link
EP (1) EP0358692B1 (de)
JP (1) JP2777894B2 (de)
AT (1) ATE166880T1 (de)
AU (1) AU629793B2 (de)
DE (1) DE3856199T2 (de)
FI (1) FI895108A0 (de)
HU (1) HU205372B (de)
WO (1) WO1988008431A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988008430A1 (en) * 1987-04-27 1988-11-03 Commonwealth Scientific And Industrial Research Or Peptide production by protein engineering
SE462285B (sv) * 1988-09-16 1990-05-28 Jan Roland Holmgren Expression av koleratoxinets bindande subenhet med hjaelp av fraemmande promotor- och/eller ledarpeptidstrukturer
KR102107332B1 (ko) * 2019-03-20 2020-05-07 (주)제이비바이오텍 CRISPR/Cas9 기반 Bacillus subtillis 유전체 편집 메커니즘을 이용한 콜레라 백신

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243025A (ja) * 1984-05-17 1985-12-03 Eiken Kagaku Kk コレラトキシンサブユニツトbの製造法

Also Published As

Publication number Publication date
EP0358692A4 (de) 1990-07-03
JPH02503914A (ja) 1990-11-15
JP2777894B2 (ja) 1998-07-23
EP0358692B1 (de) 1998-06-03
FI895108A0 (fi) 1989-10-27
ATE166880T1 (de) 1998-06-15
AU1725788A (en) 1988-12-02
WO1988008431A1 (en) 1988-11-03
AU629793B2 (en) 1992-10-15
HUT53915A (en) 1990-12-28
DE3856199T2 (de) 1999-02-04
EP0358692A1 (de) 1990-03-21
HU205372B (en) 1992-04-28

Similar Documents

Publication Publication Date Title
ATE157397T1 (de) Lebende vakzine
DK219087D0 (da) Vektorsystem til brug ved transformation af trichoderma, transformerede trichodermastammer og fremgangsmaade til fremstilling af proteiner heri
ATE188508T1 (de) Impfstoffe gegen diphtherietoxin
DK0757717T3 (da) Papillomavirusvacciner
DE10399038I1 (de) F-Serien-Prostaglandine.
DE60038567D1 (de) Modifiziertes gp100 und dessen verwendung
DK251890D0 (da) Polypeptid og dets anvendelse samt ekspressionssystem til dets eksprimering
DE69329195T2 (de) Rekombinante dna moleküle die aminopeptidase enzyme kodieren und ihre anwendung für die herstellung von impfstoffen gegen helminth infektionen
ES547436A0 (es) Un procedimiento para producir un adn complementario clonadoo su adn modificado que codifica un polipeptido de factor denecrosis de tumores
DE3763501D1 (de) Stosswellenquelle mit piezokeramischer druckquelle.
DE3856199T2 (de) Impfstoff gegen cholera
DK186589D0 (da) E. coli-stamme til kraftig sekretion af protein til dyrkningsmediet, dens fremstilling og anvendelse
HK1048134A1 (en) Streptococcus pyogenes virulence and proteins and their use
PT744027E (pt) Utilizacao de metodos para identificar oligopeptidos de sinal hidrofilicos
FI911973A0 (fi) Traodaktigt hemagglutinin av b. pertussis-bacill.
DE3688225T2 (de) Herstellung menschlichen somatomedins c.
Lewin Recent experience with chemical techniques of stone preservation
DE68918189T2 (de) Neisseria-Vakzine.
ATE152916T1 (de) Die verwendung von anti-helminth impfstoffen zur kontrolle von parasitären krankheiten, die mit einem verlust der natürlichen immunität assoziiert sind
NO910331D0 (no) Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.
WO2001057075A3 (en) Virulence genes, proteins, and their use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition